Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Goodrx Holdings Inc Cl A (GDRX)

Goodrx Holdings Inc Cl A (GDRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 814,639
  • Shares Outstanding, K 339,433
  • Annual Sales, $ 792,320 K
  • Annual Income, $ 16,390 K
  • EBIT $ 164 M
  • EBITDA $ 236 M
  • 60-Month Beta 1.45
  • Price/Sales 1.10
  • Price/Cash Flow 7.36
  • Price/Book 1.32

Options Overview Details

View History
  • Implied Volatility 107.22% (-21.58%)
  • Historical Volatility 38.47%
  • IV Percentile 82%
  • IV Rank 42.44%
  • IV High 174.19% on 12/29/25
  • IV Low 57.83% on 03/05/25
  • Expected Move (DTE 21) 0.44 (19.47%)
  • Put/Call Vol Ratio 0.05
  • Today's Volume 3,031
  • Volume Avg (30-Day) 1,886
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 53,877
  • Open Int (30-Day) 63,756
  • Expected Range 1.83 to 2.71

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.05
  • Number of Estimates 4
  • High Estimate 0.06
  • Low Estimate 0.04
  • Prior Year 0.04
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.24 +0.71%
on 01/30/26
2.96 -23.79%
on 01/13/26
-0.43 (-16.14%)
since 12/30/25
3-Month
2.24 +0.71%
on 01/30/26
3.55 -36.46%
on 10/31/25
-1.18 (-34.42%)
since 10/30/25
52-Week
2.24 +0.71%
on 01/30/26
5.81 -61.17%
on 10/09/25
-2.69 (-54.43%)
since 01/30/25

Most Recent Stories

More News
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question

1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question

GDRX : 2.27 (-5.42%)
BLBD : 50.46 (+1.73%)
MED : 11.39 (+2.15%)
GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full...

GDRX : 2.27 (-5.42%)
Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks

Q3 Earnings Highlights: GoodRx (NASDAQ:GDRX) Vs The Rest Of The Healthcare Technology Stocks

GDRX : 2.27 (-5.42%)
Surescripts and GoodRx Partner to Advance Patient Price Transparency

Surescripts Introduces New Patient Experience Solution to Transform the Medication Experience and Improve Patient Access, Affordability and Adherence

GDRX : 2.27 (-5.42%)
GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies

Program offers Giant Eagle customers instant access to meaningful savings on brand medications

GDRX : 2.27 (-5.42%)
GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill

Consumers can soon go to GoodRx for Weight Loss to determine eligibility and obtain a prescription for the first and only oral GLP-1 formulation

GDRX : 2.27 (-5.42%)
1 Cash-Producing Stock to Keep an Eye On and 2 We Avoid

1 Cash-Producing Stock to Keep an Eye On and 2 We Avoid

GDRX : 2.27 (-5.42%)
GM : 84.00 (-2.62%)
BBSI : 37.93 (+3.30%)
1 Value Stock to Target This Week and 2 Facing Headwinds

1 Value Stock to Target This Week and 2 Facing Headwinds

GDRX : 2.27 (-5.42%)
PUBM : 7.23 (-2.95%)
URBN : 70.85 (+1.26%)
3 Healthcare Stocks We Approach with Caution

3 Healthcare Stocks We Approach with Caution

AMN : 21.09 (+4.46%)
GDRX : 2.27 (-5.42%)
PGNY : 23.92 (-0.83%)
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced that executives from the Company will participate...

GDRX : 2.27 (-5.42%)

Business Summary

GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California.

See More

Key Turning Points

3rd Resistance Point 2.64
2nd Resistance Point 2.53
1st Resistance Point 2.47
Last Price 2.27
1st Support Level 2.29
2nd Support Level 2.18
3rd Support Level 2.12

See More

52-Week High 5.81
Fibonacci 61.8% 4.45
Fibonacci 50% 4.02
Fibonacci 38.2% 3.60
Last Price 2.27
52-Week Low 2.24

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar